Causey et al.75 reported that PGRMC1 mRNA levels were significantly lower in stage II breast cancer patients than in stage III breast cancer patients, so measurement of PGRMC2 mRNA might be useful for the staging of breast adenocarcinoma. Here, PGRMC2 is linked to breast cancer.